脳腫瘍診断・治療薬市場：タイプ、適応症、流通チャネル別-2025-2030年の世界予測

脳腫瘍診断・治療薬市場は、2023年に16億3,000万米ドルと評価され、2024年には17億8,000万米ドルに達すると予測され、CAGR 9.37％で成長し、2030年には30億6,000万米ドルに達すると予測されています。

脳腫瘍診断・治療薬市場の対象範囲には、良性および悪性の両方を含む脳腫瘍の診断ツールおよび治療オプションが含まれます。先進的な診断および治療ソリューションの必要性は、脳腫瘍の発生率の増加、急速な技術進歩、早期かつ正確な診断に対するアンメットニーズによってもたらされています。主な用途には、MRIやCTなどの画像検査、生検技術、化学療法、放射線療法、標的療法などの革新的治療法があります。最終用途分野は主に病院、診断センター、研究機関です。市場成長は、診断技術の進歩、早期発見に関する意識の高まり、ヘルスケア支出の増加といった要因に大きく影響されます。さらに、有望な薬剤のパイプラインが充実していることや、精密医療におけるブレークスルーが市場拡大の大きなチャンスとなっています。企業は、研究開発への投資やヘルスケア機関との戦略的提携により、こうした機会を捉えることができます。しかし、市場の成長には、高い治療費、厳しい規制要件、新興地域における限られたアクセシビリティが課題となっています。費用対効果の高い戦略を導入し、複雑な規制をうまく乗り切ることが、市場の成功には不可欠です。イノベーション分野には、非侵襲的診断ツールの開発、個別化医療、画像技術へのAIの統合などがあります。これらの進歩は、患者中心の医療と精密治療に焦点を当てた新たなビジネスモデルを推進する可能性があります。市場には豊富な成長の可能性があるが、企業は機会を効果的に活用するために、規制への対応、患者の負担軽減、技術統合に注力する必要があります。治療の副作用を軽減し、診断の精度と効率を向上させるための調査への継続的な投資は、市場の実行可能性をさらに高めると思われます。市場の性質はダイナミックであり、低侵襲アプローチと精密医療に向かう傾向があるため、企業は徹底した市場調査と戦略的計画に取り組んで競争力を維持することが最も重要です。

市場力学：急速に進化する脳腫瘍診断・治療薬市場の主要市場インサイトを公開

脳腫瘍診断・治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 神経疾患の有病率の増加
  • 腫瘍の存在を検出する検査の必要性
  • 分子診断学における調査活動
• 市場抑制要因
  • 診断と治療に伴う高コスト
• 市場機会
  • ヘルスケア支出の増加と有利な償還政策
  • がん啓発のための政府の取り組み
• 市場の課題
  • 脳腫瘍治療薬に伴う副作用

ポーターの5つの力：脳腫瘍診断・治療薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：脳腫瘍診断・治療薬市場における外部からの影響の把握

外部マクロ環境要因は、脳腫瘍診断・治療薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析脳腫瘍診断・治療薬市場における競合情勢の把握

脳腫瘍診断・治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス脳腫瘍診断・治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、脳腫瘍診断・治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨脳腫瘍診断・治療薬市場における成功への道筋を描く

脳腫瘍診断・治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 神経疾患の罹患率の増加
    • 腫瘍の存在を検出する検査の必要性
    • 分子診断に関する調査活動
  • 抑制要因
    • 診断と治療にかかる高額な費用
  • 機会
    • ヘルスケア費の増大と有利な償還政策
    • がん啓発のための政府の取り組み
  • 課題
    • 脳腫瘍治療に伴う副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 脳腫瘍診断・治療薬市場：タイプ別

• 診断
  • 脳動脈造影
  • CTスキャン
  • 脳波
  • 腰椎穿刺
  • 分子検査
  • MRI
  • PET-CTスキャン
  • 組織サンプル採取
• 治療薬
  • 化学療法
  • 免疫療法
  • 放射線治療
  • 手術
  • 標的療法

第7章 脳腫瘍診断・治療薬市場適応症別

• 神経膠芽腫
• 髄膜腫
• 下垂体腫瘍

第8章 脳腫瘍診断・治療薬市場：流通チャネル別

• オフライン
  • 診断センター
  • 病院・クリニック
  • 小売薬局
• オンライン

第9章 南北アメリカの脳腫瘍診断・治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の脳腫瘍診断・治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの脳腫瘍診断・治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AstraZeneca PLC
• Bayer AG
• Bristol-Myers Squibb Co
• Carestream Health, Inc.
• Eisai Co., Ltd.
• F. Hoffmann-La Roche AG
• Fujifilm Corporation
• GE Healthcare Inc.
• GlaxoSmithKline PLC
• Hologic, Inc.
• Illumina, Inc.
• Invitae Corporation
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Merck & Co. Inc.
• NantOmics
• NeoGenomics Laboratories, Inc.
• Novartis AG
• Oncologica Limited
• Pfizer, Inc.
• S&P Global Inc.
• Shimadzu Corporation
• Siemens Healthineers AG

LIST OF FIGURES

• FIGURE 1. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 58. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CANADA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 89. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 90. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. CHINA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 95. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 96. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 97. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. INDIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 198. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 199. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 201. ITALY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 222. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 223. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 225. POLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 228. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 229. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 230. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 231. QATAR BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 286. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 287. BRAIN TUMOR DIAGNOSIS & THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Brain Tumor Diagnosis & Therapeutics Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.78 billion in 2024, and is projected to grow at a CAGR of 9.37%, to USD 3.06 billion by 2030.

The scope of the Brain Tumor Diagnosis & Therapeutics market encompasses diagnostic tools and treatment options for brain tumors, including both benign and malignant types. The necessity for advanced diagnostic and therapeutic solutions is driven by the increasing incidence of brain tumors, rapid technological advancements, and the unmet need for early and accurate diagnosis. Key applications include imaging scans such as MRI and CT, biopsy techniques, and innovative treatment methods like chemotherapy, radiotherapy, and targeted therapies. End-use segments primarily consist of hospitals, diagnostic centers, and research institutions. Market growth is significantly influenced by factors such as advancements in diagnostic technologies, rising awareness regarding early detection, and increasing healthcare expenditure. Furthermore, the substantial pipeline of promising drugs and breakthroughs in precision medicine offers considerable opportunities for market expansion. Companies can seize these opportunities by investing in R&D and forming strategic alliances with healthcare institutions. However, market growth is challenged by high treatment costs, stringent regulatory requirements, and limited accessibility in emerging regions. Implementing cost-effective strategies and navigating complex regulations is vital for market success. Innovation areas include the development of non-invasive diagnostic tools, personalized medicine, and integrating AI in imaging technologies. These advancements could drive new business models focusing on patient-centric care and precision therapeutics. While the market presents abundant growth potential, companies must focus on regulatory compliance, patient affordability, and technological integration to harness opportunities effectively. Continuous investment in research to reduce side effects of treatments and improve accuracy and efficiency of diagnostics will further enhance market viability. The nature of the market is dynamic, with a trend towards minimally invasive approaches and precision medicine, making it paramount for businesses to engage in thorough market research and strategic planning to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Tumor Diagnosis & Therapeutics Market

The Brain Tumor Diagnosis & Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of neurological disorders
  • Need for tests detecting the presence of tumors
  • Research activities in the molecular diagnostics
• Market Restraints
  • High cost associated with the diagnosis and treatment
• Market Opportunities
  • Rising healthcare expenditure and the favorable reimbursement policies
  • Government initiatives for cancer awareness
• Market Challenges
  • Side effects associated with brain tumor therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Brain Tumor Diagnosis & Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Tumor Diagnosis & Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Tumor Diagnosis & Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Tumor Diagnosis & Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Tumor Diagnosis & Therapeutics Market

A detailed market share analysis in the Brain Tumor Diagnosis & Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Tumor Diagnosis & Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Tumor Diagnosis & Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Tumor Diagnosis & Therapeutics Market

A strategic analysis of the Brain Tumor Diagnosis & Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Tumor Diagnosis & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co, Carestream Health, Inc., Eisai Co., Ltd., F. Hoffmann-La Roche AG, Fujifilm Corporation, GE Healthcare Inc., GlaxoSmithKline PLC, Hologic, Inc., Illumina, Inc., Invitae Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Merck & Co. Inc., NantOmics, NeoGenomics Laboratories, Inc., Novartis AG, Oncologica Limited, Pfizer, Inc., S&P Global Inc., Shimadzu Corporation, and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Brain Tumor Diagnosis & Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diagnosis and Therapeutics. The Diagnosis is further studied across Cerebral Arteriogram, CT Scan, EEG, Lumbar Puncture, Molecular Testing, MRI, PET-CT Scan, and Tissue Sampling. The Therapeutics is further studied across Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Targeted Therapy.
• Based on Indication, market is studied across Glioblastoma, Meningioma, and Pituitary Tumors.
• Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Diagnostic Centers, Hospital & Clinics, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of neurological disorders
    • 5.1.1.2. Need for tests detecting the presence of tumors
    • 5.1.1.3. Research activities in the molecular diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the diagnosis and treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising healthcare expenditure and the favorable reimbursement policies
    • 5.1.3.2. Government initiatives for cancer awareness
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with brain tumor therapeutics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Brain Tumor Diagnosis & Therapeutics Market, by Type

• 6.1. Introduction
• 6.2. Diagnosis
  • 6.2.1. Cerebral Arteriogram
  • 6.2.2. CT Scan
  • 6.2.3. EEG
  • 6.2.4. Lumbar Puncture
  • 6.2.5. Molecular Testing
  • 6.2.6. MRI
  • 6.2.7. PET-CT Scan
  • 6.2.8. Tissue Sampling
• 6.3. Therapeutics
  • 6.3.1. Chemotherapy
  • 6.3.2. Immunotherapy
  • 6.3.3. Radiation Therapy
  • 6.3.4. Surgery
  • 6.3.5. Targeted Therapy

7. Brain Tumor Diagnosis & Therapeutics Market, by Indication

• 7.1. Introduction
• 7.2. Glioblastoma
• 7.3. Meningioma
• 7.4. Pituitary Tumors

8. Brain Tumor Diagnosis & Therapeutics Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
  • 8.2.1. Diagnostic Centers
  • 8.2.2. Hospital & Clinics
  • 8.2.3. Retail Pharmacies
• 8.3. Online

9. Americas Brain Tumor Diagnosis & Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Brain Tumor Diagnosis & Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Brain Tumor Diagnosis & Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AstraZeneca PLC
• 3. Bayer AG
• 4. Bristol-Myers Squibb Co
• 5. Carestream Health, Inc.
• 6. Eisai Co., Ltd.
• 7. F. Hoffmann-La Roche AG
• 8. Fujifilm Corporation
• 9. GE Healthcare Inc.
• 10. GlaxoSmithKline PLC
• 11. Hologic, Inc.
• 12. Illumina, Inc.
• 13. Invitae Corporation
• 14. Johnson & Johnson Services, Inc.
• 15. Koninklijke Philips N.V.
• 16. Merck & Co. Inc.
• 17. NantOmics
• 18. NeoGenomics Laboratories, Inc.
• 19. Novartis AG
• 20. Oncologica Limited
• 21. Pfizer, Inc.
• 22. S&P Global Inc.
• 23. Shimadzu Corporation
• 24. Siemens Healthineers AG